• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于无法治愈的宫颈癌患者,应采取何种恰当的治疗方法?

What is the appropriate approach to treating women with incurable cervical cancer?

机构信息

Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

出版信息

J Natl Compr Canc Netw. 2013 Mar 1;11(3):348-55. doi: 10.6004/jnccn.2013.0044.

DOI:10.6004/jnccn.2013.0044
PMID:23486459
Abstract

Women should not die of cervical cancer...but they do. Most cases of cervical cancer are preventable and, if caught early, highly curable. Despite this, cervical cancer is the second most common cause of cancer death in women worldwide. Unfortunately, cure is less likely when the disease is diagnosed at an advanced stage. Treatment of locally advanced disease often has serious lifelong side effects, including cystitis, proctitis, intestinal strictures, fistulas, vaginal agglutination/sexual dysfunction, and chronic pain. Unresectable recurrent disease may be associated with all these symptoms, in addition to disturbing malodorous discharge and bleeding and a life expectancy of less than 6 to 10 months. Supportive/palliative care interventions are needed at diagnosis and recurrence. Honest, conflict-free conversations about potential for response and expectations are needed for women with recurrent disease to help preserve and improve quality of life and avoid treatments that offer no benefit. Aims of trial design should include not only molecular targeting but also supportive care objectives, such as reducing pain, anxiety, depression, cachexia, and fatigue. A β-adrenergic blockade could potentially be part of these intervention trials. This article addresses the following questions and issues: whether therapeutic treatment of incurable cervical cancer is ever appropriate, the common symptoms of recurrent cervical cancer, the quantifying benefits of treatment, decision aids in treatment planning, doctor-patient candor, and integrating psychosocial factors into treatment.

摘要

女性不应该死于宫颈癌……但她们确实会。大多数宫颈癌病例是可以预防的,如果早期发现,治愈率很高。尽管如此,宫颈癌仍是全球女性癌症死亡的第二大常见原因。不幸的是,当疾病处于晚期诊断时,治愈的可能性较小。局部晚期疾病的治疗通常会产生严重的终身副作用,包括膀胱炎、直肠炎、肠狭窄、瘘管、阴道粘连/性功能障碍和慢性疼痛。不可切除的复发性疾病除了令人讨厌的恶臭分泌物和出血以及预期寿命不到 6 至 10 个月之外,还可能伴有所有这些症状。在诊断和复发时需要进行支持性/姑息治疗干预。对于复发性疾病的女性,需要进行诚实、无冲突的关于反应可能性和期望的对话,以帮助保留和改善生活质量,并避免提供无益的治疗。试验设计的目标不仅应包括分子靶向,还应包括支持性护理目标,如减轻疼痛、焦虑、抑郁、恶病质和疲劳。β肾上腺素能阻断可能是这些干预试验的一部分。本文讨论了以下问题和问题:治疗无法治愈的宫颈癌是否合适,复发性宫颈癌的常见症状,治疗的量化收益,治疗计划中的决策辅助工具,医生与患者的坦诚相待,以及将社会心理因素纳入治疗。

相似文献

1
What is the appropriate approach to treating women with incurable cervical cancer?对于无法治愈的宫颈癌患者,应采取何种恰当的治疗方法?
J Natl Compr Canc Netw. 2013 Mar 1;11(3):348-55. doi: 10.6004/jnccn.2013.0044.
2
Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.晚期宫颈癌控制阴道出血的姑息性干预措施。
Cochrane Database Syst Rev. 2015 May 1;2015(5):CD011000. doi: 10.1002/14651858.CD011000.pub2.
3
Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Cervical Cancer.关于照顾宫颈癌患者,姑息治疗临床医生应该知道的十大要点。
J Palliat Med. 2021 Mar;24(3):438-442. doi: 10.1089/jpm.2021.0006. Epub 2021 Jan 29.
4
The centrality of the clinician in the evaluation of patients with abnormal cervical cytologic studies.临床医生在宫颈细胞学检查异常患者评估中的核心地位。
Am J Obstet Gynecol. 2002 Dec;187(6):1533-5. doi: 10.1067/mob.2002.127308.
5
The impact of cervical cancer on quality of life--the components and means for management.宫颈癌对生活质量的影响——管理的组成部分及方法
Gynecol Oncol. 2007 Dec;107(3):572-7. doi: 10.1016/j.ygyno.2007.09.019. Epub 2007 Oct 25.
6
A systematic review of the supportive care needs of women living with and beyond cervical cancer.对宫颈癌患者及康复期女性支持性护理需求的系统评价。
Gynecol Oncol. 2015 Mar;136(3):478-90. doi: 10.1016/j.ygyno.2014.10.030. Epub 2014 Nov 20.
7
Decision making at a time of crisis near the end of life.临终危机时刻的决策。
JAMA. 2004 Oct 13;292(14):1738-43. doi: 10.1001/jama.292.14.1738.
8
Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review.一线铂类方案治疗后复发/晚期宫颈癌患者的管理:我们目前的状况如何?文献综述
Crit Rev Oncol Hematol. 2016 Dec;108:164-174. doi: 10.1016/j.critrevonc.2016.11.006. Epub 2016 Nov 15.
9
Cervical cancer.宫颈癌
Lancet. 2003 Jun 28;361(9376):2217-25. doi: 10.1016/S0140-6736(03)13778-6.
10
The informational needs of newly diagnosed cervical cancer patients who will be receiving combined chemoradiation treatment.即将接受同步放化疗的新诊断宫颈癌患者的信息需求。
J Cancer Educ. 2006 Winter;21(4):263-8. doi: 10.1080/08858190701347937.

引用本文的文献

1
Chemo-radiotherapy after neoadjuvant chemotherapy and radical hysterectomy in women with stage IB-IIB cervical cancer: Do we need to change the therapeutic approach? A cohort study.IB-IIB期宫颈癌女性新辅助化疗及根治性子宫切除术后的放化疗:我们是否需要改变治疗方法?一项队列研究。
Surg Pract Sci. 2025 Apr 28;21:100284. doi: 10.1016/j.sipas.2025.100284. eCollection 2025 Jun.
2
Different surgical methods for FIGO stage IVB cervical cancer patients receiving chemotherapy: a population-based study.FIGO IVB期宫颈癌患者接受化疗的不同手术方法:一项基于人群的研究。
J Gynecol Oncol. 2025 May;36(3):e42. doi: 10.3802/jgo.2025.36.e42. Epub 2024 Oct 22.
3
Prediction and Detection of Cervical Malignancy Using Machine Learning Models.
基于机器学习模型预测和检测宫颈癌。
Asian Pac J Cancer Prev. 2023 Apr 1;24(4):1419-1433. doi: 10.31557/APJCP.2023.24.4.1419.
4
Opioid Use in Patients With Cervical Cancer at Two Urban Medical Centers.两家城市医疗中心宫颈癌患者的阿片类药物使用情况
Adv Radiat Oncol. 2021 Oct 20;7(2):100833. doi: 10.1016/j.adro.2021.100833. eCollection 2022 Mar-Apr.
5
Role of locoregional surgery in treating FIGO 2009 stage IVB cervical cancer patients: a population-based study.局部区域性手术在治疗 FIGO 2009 分期 IVB 期宫颈癌患者中的作用:一项基于人群的研究。
BMJ Open. 2021 Aug 11;11(8):e042364. doi: 10.1136/bmjopen-2020-042364.
6
Induction of Micronuclei in Cervical Cancer Treated with Radiotherapy.放射治疗的宫颈癌中微核的诱导
J Pers Med. 2020 Sep 3;10(3):110. doi: 10.3390/jpm10030110.
7
Supervised Algorithms of Machine Learning for the Prediction of Cervical Cancer.用于预测宫颈癌的机器学习监督算法
J Biomed Phys Eng. 2020 Aug 1;10(4):513-522. doi: 10.31661/jbpe.v0i0.1912-1027. eCollection 2020 Aug.
8
Sustainable Tumor-Suppressive Effect of iPSC-Derived Rejuvenated T Cells Targeting Cervical Cancers.iPSC 衍生的靶向宫颈癌的复壮 T 细胞的可持续肿瘤抑制作用。
Mol Ther. 2020 Nov 4;28(11):2394-2405. doi: 10.1016/j.ymthe.2020.07.004. Epub 2020 Jul 9.
9
Discovery of microarray-identified genes associated with the progression of cervical intraepithelial neoplasia.发现与宫颈上皮内瘤变进展相关的微阵列鉴定基因。
Int J Clin Exp Pathol. 2018 Dec 1;11(12):5667-5681. eCollection 2018.
10
T-Cell Receptor Gene Therapy for Human Papillomavirus-Associated Epithelial Cancers: A First-in-Human, Phase I/II Study.T 细胞受体基因疗法治疗人乳头瘤病毒相关上皮性肿瘤:首例人体、I/II 期研究。
J Clin Oncol. 2019 Oct 20;37(30):2759-2768. doi: 10.1200/JCO.18.02424. Epub 2019 Aug 13.